AwesomeCapital: Nurix gets FDA clearance to initiate trial for its anti-inflammatory drug candidate

Thursday, April 17, 2025

Nurix gets FDA clearance to initiate trial for its anti-inflammatory drug candidate

Nurix Therapeutics and Gilead secure FDA IND clearance for GS-6791, targeting IRAK4 protein in inflammatory conditions.

https://seekingalpha.com/news/4432156-nurix-gets-fda-clearance-to-initiate-trial-for-its-anti-inflammatory-drug-candidate

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)